Marico Buys 60% of Cosmix Wellness for ₹375 Cr to Bolster Digital Health

Marico Ltd. has strategically bolstered its burgeoning digital-first wellness portfolio by acquiring a 60% stake in Cosmix Wellness Private Ltd. for ₹375 crore. This acquisition introduces a rapidly scaling, bootstrapped brand with robust margins into Marico's existing stable of consumer goods, signaling a focused push into India's expanding health and wellness sector. The deal values Cosmix at approximately ₹375 crore, with founders retaining the remaining stake and leadership. This investment aligns with Marico's overarching strategy to capture growth in high-demand segments, building on its established presence in consumer staples and personal care. Marico, a Mumbai-based conglomerate with brands like Parachute and Saffola, operates with a market capitalization of roughly ₹95,000 crore and a P/E ratio of approximately 55.34, reflecting investor confidence in its diversified growth trajectory.

The Wellness Pivot

Marico's entry into the plant-based nutrition space via Cosmix underscores a deliberate strategy to tap into India's rapidly growing health and wellness market, estimated to be worth USD 78 billion and projected for robust expansion. Cosmix, founded in 2019, has carved out a significant niche with its plant-based protein powders and functional superfood blends, achieving an annual revenue run rate of ₹100 crore. Crucially, the brand has maintained high-teen EBITDA margins while remaining bootstrapped and profitable since its inception, presenting a financially sound asset for Marico. This acquisition positions Marico to capitalize on evolving consumer preferences for natural, plant-based, and health-conscious products, a trend that is significantly reshaping the fast-moving consumer goods (FMCG) sector.

Cosmix: A Premium Asset

Cosmix's operational efficiency and market penetration are key highlights of this transaction. Its status as a top-selling brand in the plant protein category across major e-commerce platforms, coupled with strong direct-to-consumer (D2C) performance metrics like high repeat purchase rates and customer lifetime value, indicates deep consumer resonance [cite: Source A]. The brand's commitment to clean ingredients and transparent communication aligns well with contemporary consumer demands. With competitors like OZiva and Wellbeing Nutrition also active in this space, Cosmix's established market position and demonstrated profitability offer Marico a distinct advantage. The valuation of ₹375 crore for 60% of the company reflects the premium commanded by profitable, digitally-native brands in the wellness segment.

Marico's Inorganic Growth Engine

This acquisition follows Marico's recent purchase of premium snacking brand 4700BC for ₹226.83 crore in January 2026, reinforcing its inorganic growth strategy in differentiated categories. Marico's digital-first portfolio already includes brands like Plix, True Elements, Beardo, and Just Herbs, with its collective digital brands surpassing ₹1,000 crore in annual recurring revenue by late 2025. The company aims for its food and premium personal care segments to contribute at least 25% of its India business by 2028. Marico's stock has shown resilience, with a recent one-year change of over 10% and an average analyst price target suggesting further upside, supported by a consensus 'Buy' rating.

Future Trajectory

Saugata Gupta, MD and CEO of Marico Ltd., emphasized the strategic importance of Cosmix in adding a differentiated brand to their digital-first portfolio and leveraging synergies for accelerated growth in adjacent wellness categories [cite: Source A]. Marico's established R&D and manufacturing capabilities are expected to further enhance Cosmix's product development and market reach. The company holds the right to acquire the remaining stake in Cosmix post-fiscal year 2029, contingent on performance milestones, indicating a long-term commitment to integrating and scaling the brand within its expanding wellness ecosystem.